(NASDAQ: NTRA) Natera's forecast annual revenue growth rate of 10.65% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.08%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.68%.
Natera's revenue in 2025 is $2,116,674,000.On average, 24 Wall Street analysts forecast NTRA's revenue for 2025 to be $294,384,853,845, with the lowest NTRA revenue forecast at $277,409,074,650, and the highest NTRA revenue forecast at $306,392,112,300. On average, 24 Wall Street analysts forecast NTRA's revenue for 2026 to be $339,791,612,830, with the lowest NTRA revenue forecast at $314,672,980,200, and the highest NTRA revenue forecast at $372,639,055,500.
In 2027, NTRA is forecast to generate $398,309,745,990 in revenue, with the lowest revenue forecast at $343,379,988,920 and the highest revenue forecast at $451,307,300,550.